Dealmaking

Parthenon readies sale of Trinity Life Sciences

The anticipated sale process comes fresh on the heels of GHO Capital’s recent $700m-plus bet for another life sciences strategy consulting business, ClearView Healthcare Partners.

Reify Health hits $2.2bn valuation with Coatue Management-led investment

Coatue Management, ICONIQ Capital and Adams Street join hands to invest in a company looking to revolutionize how patients access and are enrolled in clinical trials.

What the $1 trillion infrastructure bill means for clean energy PE investors

GPs investing in sustainable infrastructure talk about the under consideration $1 trillion infra bill.

Private Equity Jobs of the Week: Bain Capital, AIG and Blackstone are hiring

This week’s jobs include a VP at AIG Investments and associate spots at Bain Capital and Blackstone.

Avista to make 3.7x its money on Arcadia Consumer Healthcare; Great Point Partners' Softbox hits the market

Avista sells Arcadia Consumer Healthcare and GPP seeks buyer for Softbox.

Avista to make 3.7 times its money with sale of Arcadia Consumer Healthcare

Accounting for Arcadia proceeds and prior Fund 4 exits – Organogensis and MPI Research – the vehicle will have returned approximately $1.4bn to investors, according to an LP letter.

Great Point Partners brings Softbox to market

After seven years, the firm looks to exit its investment in the provider of passive containers that ship temperature-sensitive commercial and clinical trial products.

TPG bets on government digitization with Government Brands

As the general population continues to integrate technology more and more into their daily lives, there is a certain level of digital aptitude that they expect from their towns and cities, according to TPG's Millikin.

De-mystifying the de-SPAC: regulation and risk in life sciences transactions

For the SPAC sponsor, without the benefit of the portfolio risk management of a venture fund, the risk-reward profile for a private biotech acquisition is not for the faint of heart.

PAI Partners aims to bring 'newness' to $4.5bn PepsiCo carveout, Peak Rock inks first Fund 3 deal

PAI Partners plunges into North America with PepsiCo carveout.